Table 2 Diagnostic yield per initial diagnosis of the proband.

From: Highly efficient capture approach for the identification of diverse inherited retinal disorders

Phenotype

Female

(%)

Solved rate

(%)

Receive molecular diagnosis (%)

Sporadic

(%)

Age

(range)

Onset age

(range)

VA (OD)

(Range)

VA (OS)

(range)

AS

0/1

0.00

0/1

0.00

0/1

0.00

1/1

100.0

57.8

(57.8, 57.8)

48.0

(48.0, 48.0)

0.2

(0.16, 0.16)

2.4

(2.40, 2.40)

BBS

1/2

50.00

1/2

50.00

1/2

50.0

1/2

50.0

47.8

(29.5, 66.2)

19.0

(3.00, 35.0)

2.4

(2.10, 2.70)

2.6

(2.40, 2.70)

BCD

9/13

69.23

12/13

92.31

12/13

92.3

10/13

76.9

57.2

(40.0, 76.9)

32.8

(20.0, 45.0)

1.1

(0.00, 2.70)

1.1

(0.22, 2.70)

BVMD

0/1

0.00

1/1

100.00

1/1

100.0

0/1

0.00

62.4

(62.4, 62.4)

40.0

(40.0, 40.0)

1.8

(1.78, 1.78)

1.3

(1.30, 1.30)

CD

2/2

100.00

1/2

50.00

2/2

100.0

2/2

100.0

51.5

(35.5, 67.4)

31.5

(3.00, 60.0)

0.9

(0.22, 1.52)

1.5

(1.30, 1.70)

Choroideremia

1/9

11.11

7/9

77.78

7/9

77.8

2/9

22.2

47.8

(19.9, 66.5)

21.9

(1.00, 55.0)

0.8

(0.00, 2.40)

0.8

(0.00, 2.70)

CRD

17/43

39.53

23/43

53.48

30/43

69.8

29/43

67.4

50.6

(17.9, 72.7)

26.8

(3.00, 65.0)

1.5

(0.00, 3.00)

1.3

(0.00, 3.00)

LCA

15/19

78.95

16/19

84.21

17/19

89.5

15/19

78.9

34.4

(1.83, 82.3)

9.41

(0.50, 46.0)

1.4

(0.00, 2.70)

1.4

(0.00, 2.70)

MD

5/9

55.56

4/9

44.44

7/9

77.8

6/9

66.7

58.4

(26.0, 74.1)

38.0

(15.0, 63.0)

0.5

(0.00, 1.30)

1.0

(0.00, 2.40)

Optic atrophy

1/1

100.00

1/1

100.00

1/1

100.0

1/1

100.0

12.2

(12.2, 12.2)

3.00

(3.00, 3.00)

0.8

(0.80, 0.80)

0.8

(0.80, 0.80)

RP

136/273

49.82

128/273

46.89

168/273

61.5

193/273

70.7

50.9

(0.00, 96.4)

25.8

(0.25, 74.0)

1.1

(0.00, 3.00)

1.1

(0.00, 3.00)

RPA

1/2

50.00

2/2

100.00

2/2

100.0

1/2

50.0

37.6

(21.6, 53.6)

16.5

(3.00, 30.0)

0.7

(0.10, 1.30)

1.4

(1.00, 1.70)

RS

0/2

0.00

2/2

100.00

2/2

100.0

0/2

0.00

19.3

(15.3, 23.3)

7.00

(7.00, 7.00)

0.5

(0.52, 0.52)

0.5

(0.52, 0.52)

SD

2/5

40.00

5/5

100.00

5/5

100.0

5/5

100.0

37.1

(25.0, 60.2)

22.0

(6.00, 55.0)

1.3

(0.22, 2.10)

1.5

(0.52, 2.10)

SS

2/5

40.00

3/5

60.00

5/5

100.0

4/5

80.0

52.3

(4.25, 73.6)

32.9

(0.25, 50.0)

1.4

(0.16, 2.70)

1.7

(0.70, 3.00)

US

19/38

50.00

24/38

63.16

31/38

81.6

26/38

68.4

44.6

(0.00, 83.3)

23.8

(0.08, 60.0)

1.0

(0.00, 3.00)

1.0

(0.00, 3.00)

Total

211/425

49.65

229/425

53.88

291/425

68.5

296/425

69.6

49.5

(0.00, 96.4)

25.0

(0.08, 74.0)

1.1

(0.00, 3.00)

1.1

(0.00, 3.00)

  1. The table shows the clinical demographic and diagnostic yield of each IRD phenotype. Phenotype abbreviations are listed in the supplementary table. Uncertain denotes phenotypes that ophthalmologists are unable to confirm the diagnosis.
  2. AS Altrom’s syndrome, BBS Bardet Biedl’s syndrome, BCD Bietti’s crystalline dystrophy, BVMD best vitelliform macular dystrophy, CD cone dystrophy, CRD cone-rod dystrophy, LCA Leber’s congenital amaurosis, MD macular degeneration, RP retinitis pigmentosa, RPA retinitis punctata albescens, RS retinoschisis, SD Stargardt’s dystrophy, SS Stickler’s syndrome, US Usher’s syndrome.